Cargando…

Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged ≥50 Years — United States, March 29, 2022–July 10, 2022

Detalles Bibliográficos
Autores principales:	Hause, Anne M., Baggs, James, Marquez, Paige, Abara, Winston E., Baumblatt, Jane, Blanc, Phillip G., Su, John R., Hugueley, Brandon, Parker, Casey, Myers, Tanya R., Gee, Julianne, Shimabukuro, Tom T., Shay, David K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2022
Materias:	Full Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345177/ https://www.ncbi.nlm.nih.gov/pubmed/35900925 http://dx.doi.org/10.15585/mmwr.mm7130a4

Ejemplares similares

Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status — United States, January 12, 2022–March 28, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

Safety Monitoring of Pfizer-BioNTech COVID-19 Vaccine Booster Doses Among Children Aged 5–11 Years — United States, May 17–July 31, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults — United States, September 22, 2021–February 6, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12–17 Years — United States, December 9, 2021–February 20, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

COVID-19 Vaccine Safety in Adolescents Aged 12–17 Years — United States, December 14, 2020–July 16, 2021
por: Hause, Anne M., et al.
Publicado: (2021)

Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Persons Aged ≥12 Years — United States, August 31–October 23, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

COVID-19 mRNA Vaccine Safety Among Children Aged 6 Months–5 Years — United States, June 18, 2022–August 21, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

Safety Monitoring of an Additional Dose of COVID-19 Vaccine — United States, August 12–September 19, 2021
por: Hause, Anne M., et al.
Publicado: (2021)

Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the US
por: Hause, Anne M., et al.
Publicado: (2022)

Post-authorization safety surveillance of Ad.26.COV2.S vaccine: Reports to the Vaccine Adverse Event Reporting System and v-safe, February 2021–February 2022
por: Woo, Emily Jane, et al.
Publicado: (2023)

Association between history of SARS-CoV-2 infection and severe systemic adverse events after mRNA COVID-19 vaccination among U.S. adults
por: Tompkins, Lindsay K., et al.
Publicado: (2022)

Reports of Guillain-Barré Syndrome After COVID-19 Vaccination in the United States
por: Abara, Winston E., et al.
Publicado: (2023)

Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5–11 Years — United States, October 12–January 1, 2023
por: Hause, Anne M., et al.
Publicado: (2023)

COVID-19 Vaccine Safety in Children Aged 5–11 Years — United States, November 3–December 19, 2021
por: Hause, Anne M., et al.
Publicado: (2021)

Menstrual irregularities and vaginal bleeding after COVID-19 vaccination reported to v-safe active surveillance, USA in December, 2020–January, 2022: an observational cohort study
por: Wong, Karen K, et al.
Publicado: (2022)

Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance system
por: Chapin-Bardales, Johanna, et al.
Publicado: (2021)

Safety Monitoring of mRNA COVID-19 Vaccine Third Doses Among Children Aged 6 Months–5 Years — United States, June 17, 2022–May 7, 2023
por: Hause, Anne M., et al.
Publicado: (2023)

Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine — United States, March–April 2021
por: Shay, David K., et al.
Publicado: (2021)

Notes from the Field: Safety Monitoring of Novavax COVID-19 Vaccine Among Persons Aged ≥12 Years — United States, July 13, 2022–March 13, 2023
por: Romanson, Brittney, et al.
Publicado: (2023)

Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe
por: Rosenblum, Hannah G, et al.
Publicado: (2022)

Effectiveness of a Second COVID-19 Vaccine Booster Dose Against Infection, Hospitalization, or Death Among Nursing Home Residents — 19 States, March 29–July 25, 2022
por: McConeghy, Kevin W., et al.
Publicado: (2022)

In the literature: July 2022
por: Gambardella, V., et al.
Publicado: (2022)

CPD questions July 2022
Publicado: (2022)

2070. Outbreak of Crimean-Congo Hemorrhagic Fever in Kyzylorda region, Kazakhstan, March-July 2022
por: Gabdullina, Malika, et al.
Publicado: (2023)

Anxiety-Related Adverse Event Clusters After Janssen COVID-19 Vaccination — Five U.S. Mass Vaccination Sites, April 2021
por: Hause, Anne M., et al.
Publicado: (2021)

INTERNATIONAL NEWS - March 2022
Publicado: (2022)

Editors’ page‐March 2022
por: Michos, Erin D., et al.
Publicado: (2022)

COVID-19 Booster Dose Vaccination Coverage and Factors Associated with Booster Vaccination among Adults, United States, March 2022
por: Lu, Peng-jun, et al.
Publicado: (2023)

Actuarial dashboard as at 1 July 2022
Publicado: (2022)

What's Coming in Annals - July 2022
Publicado: (2022)

Recollections of the COVID-19 Epidemiological Intelligence Task Force in China CDC, July 2021 to March 2022
por: Zhou, Lei, et al.
Publicado: (2022)

Abstract Supplement Abstracts from AIDS 2022 ‐ the 24th International AIDS Conference, 29 July – 2 August 2022, Montréal, Canada & Virtual
Publicado: (2022)

SUSY Summary Plots March 2022
por: The ATLAS collaboration
Publicado: (2022)

Epilepsia Open—March 2022—Announcements
Publicado: (2022)

PRAC meeting highlights March 2022
Publicado: (2022)

Outbreaks of SARS-CoV-2 Infections in Nursing Homes during Periods of Delta and Omicron Predominance, United States, July 2021–March 2022
por: Wilson, W. Wyatt, et al.
Publicado: (2023)

Human Vaccines & Immunotherapeutics: News July 2022
por: Ellis, Ronald, et al.
Publicado: (2022)

Top EFT summary plots March 2022
por: The ATLAS collaboration
Publicado: (2022)

Human vaccines & immunotherapeutics news: March 2022
por: Ellis, Ron, et al.
Publicado: (2022)

Avian influenza overview March – June 2022
por: Adlhoch, Cornelia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hsg1k7knem0bhmargb55j11754